title: Intracellular trafficking of integrins in cancer cells.
abstract: Integrins are heterodimeric cell surface receptors, which principally mediate the interaction between cells and their extracellular microenvironments. Because of their pivotal roles in cancer proliferation, survival, invasion and metastasis, integrins have been recognized as promising targets for cancer treatment. As is the case with other receptors, the localization of integrins on the cell surface has provided opportunities to block their functions by various inhibitory monoclonal antibodies. A number of small molecule agents blocking integrin-ligand binding have also been established, and some such agents are currently on the market or in clinical trials for some diseases including cancer. This review exclusively focuses on another strategy for cancer therapy, which comes from the obligate localization of integrins on the cell surface; targeting the intracellular trafficking of integrins. A number of studies have shown the essential roles of integrin trafficking in hallmarks of cancer, such as activation of oncogenic signaling pathways as well as acquisition of invasiveness. Recent findings have shown that increased integrin recycling activity is associated with some types of gain-of-function mutations of p53, a common feature of diverse types of cancers, which also indicates that targeting integrin recycling could be widely applicable and effective against many cancers. We also discuss possible therapeutic contexts where integrin trafficking can be effectively targeted, and what molecular interfaces may hopefully be druggable.
authors.affiliation: Department of Molecular Biology Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Onodera
authors.forename: Jin-Min
authors.initials: JM
authors.lastname: Nam
authors.forename: Hisataka
authors.initials: H
authors.lastname: Sabe
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D006801:Humans; D016023:Integrins / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D021381:Protein Transport
chemical_list: D000970:Antineoplastic Agents; D016023:Integrins
keywords: Drug-resistance; Integrin; Intracellular trafficking; Invasion and metastasis; Radio-resistance; Receptor tyrosine kinases